The treatment of experimental gas gangrene caused by Clostridium perfringens was investigated by using combinations of antimicrobial agents. This study demonstrated that rifampin, penicillin, metronidazole, and clindamycin were all bactericidal against standard inocula (105 to 106 CFU). These antimicrobial agents were then administered to mice beginning 30 min after intramuscular injection of 109 CFU of C. perfringens type A.
Gas gangrene caused by Clostridium perfringens is a fulminant infection which rapidly progresses to profound shock and then death without treatment (1, 2, 10, 25) . Current therapy involves aggressive surgical debridement, administration of hyperbaric oxygen, and penicillin treatment (8, 10, 12, 14, 21, 22) . Because more than one species of clostridia may be cultured from the wound and since strains other than C. perfringens are more likely to be resistant to clindamycin, cefoxitin, chloramphenicol, and tetracycline (9, 10, 16, 26) , antibiotic resistance is an important consideration (10) in selecting an antimicrobial agent. In addition, Marrie et al. (16) and Dubreuil et al. (9) found antibiotic resistance to penicillin, tetracycline, cephalothin, clindamycin, and metronidazole among clinical isolates of C. perfringens.
For these reasons and because we recently showed that clindamycin, metronidazole, rifampin, and tetracycline are superior to penicillin in the treatment of experimental gas gangrene in mice caused by C. perfringens (25a), we investigated the efficacy of combination antimicrobial therapy in this model. Three different combination therapies were investigated: clindamycin plus penicillin, metronidazole plus penicillin, and rifampin plus penicillin. Each drug alone had demonstrated efficacy, and each combination included both a protein synthesis-inhibiting drug and a cell wall synthesisinhibiting drug.
MATERIALS AND METHODS Organism. C. perfringens ATCC 13124 was purchased in lyophilized form from the American Type Culture Collection, Rockville, Md. Organisms were maintained anaerobically in chopped meat-glucose broth and recultured every 2 weeks. The purity of C. perfringens was verified before each * Corresponding author. experiment by inoculating blood and egg agar plates and incubating them aerobically and anaerobically by using an anaerobic GasPak system (BBL Microbiology Systems, Cockeysville, Md.).
Inoculum preparation. The inoculum was prepared in basal proteose peptone medium (Difco Laboratories, Detroit, Mich.) supplemented with amino acids, salts, and vitamins to provide optimal bacterial growth and toxin production (13, (18) (19) (20) . The medium contained 2% proteose peptone, 0.5% yeast extract, 0.5% glucose, 0.05% NaCl, and trace amounts of MgSO4, FeSO4, L-cysteine, nicotinic acid, thiamine, riboflavin, pyridoxamine, and zinc (13, (18) (19) (20) . A portion (40 ml) of a 12-h culture of C. perfringens was inoculated into 4 liters of growth medium and incubated at 370C. The pH was maintained at 7 to 7.5, and nitrogen was bubbled through the culture fluid to provide proper anaerobic conditions. (The dynamics of growth and toxin production were identical to those for bacteria grown in BBL GasPak systems.) After 4 h of incubation, 600 ml of the culture fluid was removed, centrifuged at 10,000 x g for 15 min at 4°C, and suspended in 15 ml of sterile saline. Serial dilutions of washed bacteria prepared in cold saline were assayed for A650 and CFU. A standard plot of CFU against the A650 of washed C. perfringens cells was prepared so that numbers of viable bacteria could be estimated from the A650. In all instances CFU in the inoculum were Antimicrobial susceptibility testing. Serial dilutions of filter-sterilized antimicrobial stock solutions were prepared in the growth medium described above. Each assay tube held 2.9 ml of growth medium containing a serial twofold dilution of the drug suspended in growth medium (12.5 to 0.011 jig/ml) and 0.1 ml of a log-phase culture of C. perfringens containing 5 x 105 to 4 x 106 CFU. Susceptibility tests were done in duplicate for each drug concentration, and the tubes were incubated at 37°C for 18 h under anaerobic conditions by using a BBL GasPak system. The MIC was defined as the lowest antibiotic concentration that showed no turbidity after 18 h of incubation (4) . Inoculated and uninoculated tubes containing only growth medium were used as controls.
The MBC was defined as the lowest antibiotic concentration that killed 99.9% of the initial inoculum (4 Antibiotic levels in serum samples. Antibiotics were prepared and administered as described above. Mice (weight, 15 to 20 g) received two doses of antibiotic 3.5 h apart before being bled at 10, 30, or 60 min after their last antibiotic dose. The ventral tail vein of each mouse was nicked, and 0.6 to 1.0 ml of blood was collected. The blood was allowed to clot at room temperature for 30 to 60 min before centrifugation at 4,000 x g for 10 min. Serum samples from five or six mice were combined for each time, frozen at -70°C, and shipped on dry ice for assay. Normal mouse serum was supplied for dilutions and standards. All antibiotic levels were determined in duplicate by agar well diffusion bioassays performed at the Clinical Microbiology Laboratory, University Hospital, Seattle, Wash.
Statistical analysis. Data were expressed as the mean ± standard error of the mean. Comparisons of mean survival time among groups of mice with the same long-term survival were made using one-way analysis of variance and then Duncan's new multiple range test. Comparisons of the number of mice surviving at various times after inoculation (e.g., survival tables or discrete data) were made using Fisher's exact test. The level of significance was chosen at P < 0.05.
RESULTS
MICs and MBCs. The MIC and MBC were equal for each antibiotic tested and were as follows (micrograms per milliliter): clindamycin, 0.07; metronidazole, 0.69; rifampin, 0.03; and penicillin, 0.27. Since the MBCs were determined with 0.100-ml samples from MIC tubes, our values may be lower than those that would have been determined if 0.010-ml samples were used, because of an antibiotic carryover effect (23) . These results are similar to values reported by others (9, 16, 24, 25a, 26, 27 Antibiotic concentrations in serum samples. Antibiotic levels of clindamycin, metronidazole, penicillin, and rifampin in mouse sera under the experimental conditions are shown in Table 1 . All antibiotics achieved levels in serum greater than 10 times their MIC for C. perfringens, except clindamycin whose level was only 4 times the MIC, 10 min after injection at one-fourth the optimal dose. Nonetheless, these levels for clindamycin in serum are in close agreement with published values for mice (15) . All antibiotics except clindamycin also achieved levels in serum for sustained periods within the range of accepted human therapeutic values. Clindamycin at 8.6 mg/kg produced peak levels in serum of 2.7 ± 3 ,ug/ml, slightly below the human therapeutic level in serum ( higher doses of clindamycin (43 and 86 mg/kg) produced peak levels in serum of 12.1 and 19.6 ,ug/ml, respectively, although neither dose resulted in greater survival (data not shown) than that achieved with the dose reported here (8.6 mg/kg) (P > 0.05). Monotherapy of experimental gas gangrene. Significant improvement in survival at 6 h was observed with all antibiotics tested except penicillin at one-fourth the optimal dose (P < 0.05 compared with untreated controls [ Table 2 ]). By 12 h treatment only with clindamycin at 2.1 or 8.6 mg/kg or metronidazole at 75 mg/kg led to survival which was significantly greater than that of control mice (P < 0.05). At times greater than 24 h, clindamycin (8.6 mg/kg) and metronidazole (75 mg/kg) were the most efficacious treatments (P < 0.05), and the difference between survival with clindamycin and metronidazole was not significant (P > 0.05).
Combination therapy of experimental gas gangrene. Mice treated with a combination of penicillin and rifampin each at one-fourth the optimal dose (group D) had a longer mean survival time (17.1 h) than did mice treated with optimal doses of either rifampin (11 h) or penicillin (9.0 h) alone (P < 0.05). Despite this difference, the survival of mice receiving either dose of rifampin plus penicillin was significantly better than that of mice receiving higher-dose monotherapy only at 8 and 10 h (P < 0.05) ( Table 2 ). In addition, no significant differences were apparent between high-dose and low-dose combinations of penicillin plus rifampin (P > 0.05) in terms of percent survival or mean survival time.
The combination of clindamycin and penicillin each at one-fourth the optimal dose resulted in a mean survival time of 11.8 h, not significantly different from that achieved with clindamycin at one-fourth the optimal dose (group B; 13.7 h) or penicillin at one-fourth the optimal dose (group B; 7.6 h). Mortalities in mice receiving clindamycin and penicillin combination therapy each at the optimal dose were lower than those with the low-dose combination (P < 0.05) but not lower than the mortalities observed with clindamycin alone (P > 0.05).
In contrast, the survival of mice receiving combination therapy with metronidazole plus penicillin at optimal doses was less than that with metronidazole alone at the optimal dose (Table 2 and Fig. 1) . The difference was apparent at all times from 8 to 72 h and was statistically significant at 10 to 24 h (P < 0.05). DISCUSSION C. perfringens type A has been the most common causative agent of human cases of gas gangrene in civilian as well as wartime settings (1, 2, 7, 10, 14, 22) . Studies with experimental animals indicate that penicillin is the drug of choice for the prophylaxis of gas gangrene caused by this bacterium (1-3, 8, 11, 21, 27 FIG. 1 . In vivo antagonism between metronidazole and penicillin in treatment of experimental gas gangrene caused by C. perfringens. The efficacy of metronidazole and penicillin in combination was compared with that of each drug alone using optimal doses of each drug.
phylaxis have been described (5, 17) . In addition, antimicrobial resistance of Clostridium species to penicillin and other antibiotics has been detected (9, 16, 23) . The treatment of established gas gangrene is more complex, and optimal antibiotic treatment, supportive measures, and aggressive surgical debridement are essential (1, 7, 8, 10) .
Problems germane to optimal antimicrobial treatment involve tissue penetration, postantibiotic effect, inoculum effect, dynamics of bacterial killing, and perhaps toxin suppression. Traub (27) recently demonstrated the antimicrobial tolerance of some strains of C. perfringens to cefamandole, imipenem, cefuroxime, and vancomycin. We did not observe tolerance in this study, but we did observe inoculum effects in vitro with rifampin and penicillin against C. perfringens ATCC 13124. In contrast, no such effect was detected with clindamycin even with inocula of >109 CFU. This observation likely has clinical relevance, because Bullen (6) demonstrated that C. perfringens reaches concentrations of > 108 CFU/g of muscle in experimental gas gangrene. Similarly, Traub (27) demonstrated a lack of efficacy for penicillin and cephalosporins in experimental gas gangrene when high inocula (>108 CFU) of some virulent strains of C. perfringens were used to initiate infection. We previously demonstrated that penicillin is the least efficacious drug and clindamycin and metronidazole are the most efficacious in treating fulminant gas gangrene (109 CFU) in a murine model (25a) . Thus, the ineffectiveness of penicillin may have been related to the large number of bacteria at the site in vivo and to the inoculum effect observed in vitro. Penicillinase activity was not detected in cultures of this organism. Thus, the cause of the observed inoculum effect is unexplained.
Results of this study substantiate our previous finding that metronidazole and clindamycin used singly are more efficacious than penicillin (Table 2 ) and also demonstrate that combinations of antibiotics were not more efficacious than single agents. An unexpected observation was that mice treated with a combination of metronidazole and penicillin had poorer survival than animals treated with metronidazole alone at the optimal dose (Table 2 and Fig.1 ). In contrast, the combination of clindamycin and penicillin demonstrated neither additive nor antagonistic effects in vivo ( Fig. 1 and Table 2 ). The efficacy of these agents in preventing infections caused by other strains of C. perfringens or other gangrene-producing clostridial strains is unknown. Since such strains are more likely to be resistant to antibiotics (9, 10, 16), there is rationale for selecting a combination of antimicrobial agents in the treatment or prevention of such infections. Our data derived from a murine model of C. perfringens gas gangrene suggest that mortalities may be higher with some combinations (metronidazole plus penicillin) than with monotherapy (metronidazole). Clearly, additional studies are needed to compare single and combination antimicrobial therapy in a similar model of gas gangrene using other strains and species of Clostridium.
